SUBSCRIBE
SUBSCRIBE
News   Business

Anavex Life Sciences Corp. Appoints VP Business Development And VP Strategic Planning

February 7, 2007 | 
1 min read
KELOWNA, BRITISH COLUMBIA -- (MARKET WIRE) -- February 07, 2007 -- Anavex Life Sciences Corp. (OTCBB: AVXL) (the "Company") announces that Ms. Angela Vernadaki and Dr. George Kalkanis have been appointed as Officers of the Company.
People
Anavex Life Sciences Corp.
MORE ON THIS TOPIC
Accumulated problems, contradictions. Dead end, we need to go back. You cannot continue further. Complete impossibility to continue. Rejection of an idea. Hard sanctions. Fatal error.
CAR-T
Regeneron Cans 2seventy-Acquired CAR T Candidate for Lymphoma in ‘Strategic’ Move
October 24, 2025
 · 
2 min read
 · 
Tristan Manalac
Map with different syringes. Covid 19 and pandemic vaccination concept. Vector illustration
Earnings
Sanofi’s Legacy Vaccine Sales Decline As Americans Skip Flu Shots
October 24, 2025
 · 
2 min read
 · 
Annalee Armstrong
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Alector Nearly Halves Workforce Following Dementia Drug Phase III Failure
October 23, 2025
 · 
74 min read
 · 
BioSpace Editorial Staff
Earnings
MASH, Metsera Deals Send Analysts Marauding to Viking
October 23, 2025
 · 
6 min read
 · 
Annalee Armstrong